Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Edico Genome

Edico Genome

Edico Genome is a company based in San Diego, California that sells a product for processing DNA sequencing data.

A company developing bioinformatics processor chip that aids in DNA analysis

History

The company was founded in 2013 by Pieter Van Rooyen, Robert McMillen, and Michael Ruehle.

Edico Genome announced $10 million in venture capital financing in July 2014, which was led by Qualcomm Ventures and included Axon Ventures and Gregory T. Lucier, the former chairman and CEO of Life Technologies.

The processor is claimed to reduce the time needed to analyze a whole human genome, from 24 hours to 18 minutes. DRAGEN was announced in October 2014. Edico Genome made its first sale of DRAGEN in September 2014 to Sequenom, a San Diego company focused on non-invasive prenatal testing.

Illumina

On May 15, 2018, Illumina announced that it had acquired Edico Genome.

Timeline

May 2017
Edico Genome raises a $22,000,000 series B round from Axon Ventures, Dell Technologies Capital, Greg Lucier and Qualcomm Ventures.
July 2014
Edico Genome raises a $10,000,000 series A round from Axon Ventures and Qualcomm Ventures.
2013
Edico Genome was founded by Pieter van Rooyen.

Funding rounds

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Research and Markets
June 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Biotechnology Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's...
Research and Markets
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- The "Biotechnology Services Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's...

References

Golden logo
By using this site, you agree to our Terms & Conditions.